For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260423:nRSW7025Ba&default-theme=true
RNS Number : 7025B IP Group PLC 23 April 2026
FOR RELEASE ON 23 April 2026
IP Group plc - Employee Share Schemes; Director/PDMR shareholding
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"),
which invests in breakthrough science and innovation companies with the
potential to create a better future for all, announces the following in
connection with its employee share schemes.
Release of Deferred Bonus Awards
On 22 April 2026, the Group's executive directors and one other person
discharging managerial responsibilities ("PDMR") received a total of 168,957
ordinary shares of two pence each ("Shares"), resulting from the release of
Deferred Bonus Awards granted in relation to the partial deferral of annual
bonuses for the 2023 and 2024 financial years.
The delivery of the awards was satisfied through the transfer of Shares from
the Company's employee benefit trust (the "EBT"), with the balance being
settled by cash payments in an amount sufficient to meet the relevant
individuals' income and other tax liabilities in accordance with the rules of
the IP Group Share Plan ("Share Plan").
The Shares transferred to the Group's executive directors will be held by the
EBT on behalf of, and as nominee for, the executive directors in order to
facilitate the application of the Group's Post Cessation Shareholding Policy.
A copy of the Share Plan can be found at:
https://www.ipgroupplc.com/investors/corporate-governance
(https://www.ipgroupplc.com/investors/corporate-governance)
Shares in issue
As at 22 April, the Company had 883,427,642 Shares in issue and no Shares held
in treasury.
The following information is being disclosed pursuant to the requirements of
MAR.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.
DBA Release
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Greg Smith
David Baynes
Mark Reilly
2 Reason for the notification
a) Position/status Director Chief Executive Officer
Director Chief Operating and Financial Officer
PDMR Managing Partner
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name IP Group plc
b) Legal Entity Identifier 213800HG22UM138WFG43
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 2p each in IP Group plc
Identification code
ISIN: GB00B128J450
b) Nature of the transaction Release of the 2024 Deferred Bonus Awards and 2025 Deferred Bonus Awards
c) Currency GBP
d) Price(s) and volume(s) Name(s) Price(s) Volume(s)
Greg Smith Conditional Share Award 67,116
David Baynes Conditional Share Award 41,435
Mark Reilly Conditional Share Award 60,406
e) Aggregated information
-Aggregated volume 168,957
- Price
- Aggregated total 63.7p
£107,625.61
f) Date of the transaction 22 April 2026
g) Place of the transaction London Stock Exchange, Main Market
e)
Aggregated information
-Aggregated volume
- Price
- Aggregated total
168,957
63.7p
£107,625.61
f)
Date of the transaction
22 April 2026
g)
Place of the transaction
London Stock Exchange, Main Market
For more information, please contact:
IP Group plc www.ipgroupplc.com (http://www.ipgroupplc.com)
Liz Vaughan-Adams, Communications +44 (0) 20 7444 0062/+44 (0) 7979 853802
Portland
+44 (0) 7516 729702
Alex Donaldson
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future. As the most
active UK based, early stage science and technology investor, we develop and
support some of the world's most exciting businesses in healthtech, deeptech
and cleantech. Including through Parkwalk, the UK's largest growth EIS fund
manager, we back world-changing innovation emerging in leading universities
and research institutions. Our specialist investment team combines sector
expertise with an international approach. Together we have a strong track
record of success, having backed high-profile companies including Oxford
Nanopore Technologies plc, Hinge Health, Featurespace, First Light Fusion,
Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock
Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com
(https://www.ipgroupplc.com/) .
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHPPUAGCUPQGGW
Copyright 2019 Regulatory News Service, all rights reserved